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Abstract
Background: Children with human African trypanosomi-
asis (HAT) present with a range of generally non-specific
symptoms. Late diagnosis is frequent with often tragic
outcomes. Trypanosomes can infect the foetus by
crossing the placenta. Unequivocal cases of congenital
infection that have been reported include newborn
babies of infected mothers who were diagnosed with
HAT in the first 5 days of life and children of infected
mothers who had never entered an endemic country
themselves.
Methods: This review systematically summarizes the
literature on the vertical transmission of HAT, to our
knowledge for the first time. To approach the broader
aspects of the subject, articles considering the epidemi-
ology of childhood HAT and HAT in pregnancy were also
included. The HAT guidelines and technical reports of the
World Health Organisation, Me ´decins Sans Frontie `res,
Institut de Recherche pour le De ´veloppement, and of one
endemic country were reviewed.
Results: Publications describing congenital HAT are very
limited and consist only of single case reports and small
case series. Generally it is assumed to be a rare event, but
it has never been systematically investigated. In two
publications, it is hypothesized that congenital HAT
occurs more often than suspected. Not all guidelines
and not all HAT literature mention this transmission route.
Conclusions: The risk of vertical transmission is unknown.
Awareness of congenital HAT is insufficient, and as a result
opportunities for an early diagnosis in newborns may be
missed. All HAT guidelines and local HAT protocols should
stress that in endemic areas pregnant women should be
systematically checked for HAT and that newborns of HAT
infected mothers should be assessed for the disease as
soon as possible. Studies on the impact of HAT on fertility
and pregnancy and studies on congenital HAT are long
overdue.
Introduction
Human African trypanosomiasis (HAT), commonly known as
sleeping sickness, is considered as invariably fatal if left untreated.
The infection with the protozoan parasite Trypanosoma brucei
gambiense (in western and central Africa) progresses over a few
months to several years from the haemolymphatic first stage to the
meningoencephalitic second stage. Trypanosoma brucei rhodesiense (in
eastern and southern Africa) generally causes a more acute form.
Currently, 97% of all reported cases are caused by T.b. gambiense [1].
By 1960, HAT had been reduced to a very low level after large-
scale control efforts sustained during many decades. However,
shortly after these efforts were reduced or even abandoned in the
early 1960s, HAT reemerged in several countries, reaching a peak
in the mid-1990s. Since that time, the efforts of the World Health
Organization (WHO), national control programmes, bilateral
development cooperation, and non-governmental organisations
have significantly reduced the burden of sleeping sickness [1].
Nevertheless, it has become increasingly difficult to obtain sufficient
funding to sustain adequate control efforts. In 2006, although about
12,000 cases of HAT were reported by disease-endemic countries,
WHO estimated the cumulative number of people infected with
HAT at 50,000 to 70,000 [2]. The disease strikes in remote areas
and affects marginalized and poor communities. Its spread is
amplified in areas of chronic conflict, where weak health systems
and political instability interfere with prevention and control.
HAT belongs to the group of neglected tropical diseases.
Neglect can also be seen in the scarcity of research and
development for new diagnostic tools or therapeutic agents.
Although extensive basic scientific research has been done about
the trypanosomes, clinical research has been neglected [3].
Concerning HAT, Stich et al. state that ‘‘the investment in
clinical and applied aspects of research into the disease is so dire
that even small amounts of additional funding are likely to produce
disproportionately large returns’’ [3].
ChildrenwithHATpresentwitharangeofgenerallynon-specific
symptoms [4–7]. Misdiagnosis and late diagnosis of HAT is
frequent with often tragic outcomes, such as brain damage resulting
in physical and mental sequelae or death. In pregnant women,
trypanosomes can infect the foetus (vertical transmission), which is
generally considered to be a rare event [8–12]. In the following, the
literature concerning this transmission route is reviewed in regard to
the following questions: How often is congenital HAT described in
the literature? What is the risk of congenital HAT? What is the
epidemiological impact of congenital HAT?
Search Strategy and Selection Criteria
The electronic database PubMed was searched with the
keywords ‘‘African trypanosomiasis’’, ‘‘sleeping sickness’’, or ‘‘T.
brucei’’ in all possible combinations with ‘‘vertical transmission’’,
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‘‘pregnan*’’ (asterisk ‘‘*’’ as truncation symbol). The search was
neither limited by study design nor by language of publication, nor
by date of publication.
To approach the broader aspects and implications of vertical
transmission, articles considering the epidemiology of childhood
HAT and HAT in pregnancy were also searched for.
WHO Web sites were searched for relevant publications. A
technical report from WHO [13], guidelines from Me ´decins Sans
Frontie `res (MSF) [8], Institut de Recherche pour le De ´veloppe-
ment (IRD) [14], and one endemic country [15], and the latest
editions of two standard textbooks in tropical medicine [10,16],
were reviewed.
Initially, titles and abstracts were screened. Articles identified as
possibly relevant were reviewed as full text. The reference lists of
included articles were assessed for further relevant publications. All
publications describing congenital HAT were included in this
review.
Results and Discussion
Diagnosis of Congenital HAT
Most authors define congenital infection as the diagnosis of
HAT in a newborn of an infected mother within the first 5 days of
life [5,11,12,17,18]. This definition assumes that after a bite by a
tsetse fly, the dissemination of trypanosomes from the inoculation
site into the bloodstream is expected to take more than 5 days. In
the literature, different intervals are proposed before the presence
of trypanosomes in the blood can be demonstrated, for example 5
to 21 days [9] or 7 to 10 days [11]. Chambon hypothesized that
the period of dissemination into the bloodstream may be reduced
in young infants [19].
Furthermore, certain vertical transmission can be assumed in
children of an infected mother who are diagnosed with HAT and
never entered an endemic country themselves [7,11].
The diagnosis of HAT in newborns should be established
through direct parasite detection. Serological screening with the
card agglutination test (CATT) is considered less reliable in
newborns. The presence of maternal antibodies may lead to false
positive results. An immature immune response in newborns may
yield false negative results [8].
Limited Publications Describing Congenital HAT
Publications describing congenital HAT consist only of single
case reports or small case series. Since 1933, only 13 cases of
congenital infection with T.b. gambiense—diagnosed within 5 days
of life—are described in the literature [5,17,19–24]. One case of
congenital infection with T.b. rhodesiense of a 2-day-old newborn is
reported [25].
The largest case series was published by Triolo et al. in 1985
[5]. Six cases of congenital HAT were diagnosed within 5 days of
birth by direct parasite detection in the hospital of Fontem,
southwest Cameroon. All six were in the second stage of disease
(three with trypanosomes in the cerebrospinal fluid). Of these six
newborns, three were treated with Melarsoprol and left the
hospital apparently cured. Three died soon after birth before a
treatment could be started. With regard to the six mothers, five
were in the first stage with normal cerebrospinal fluid. This
suggests rapid infection and disease progression for the child in
utero. Yet, the duration of pregnancy is sufficient to allow a
normal progression to second stage disease in utero. The six cases
of congenital HAT were reported among 227 children under 6
years old diagnosed with HAT during an observation period of 17
years. Therefore, congenital HAT comprised 2.6% of the cases in
children under 6 years old.
The data on the first three of the above mentioned six cases
were already published in 1979 by Sina et al. from the same study
group. Sina et al. emphasized that these three cases were
diagnosed in a relatively short period of some few months in a
hyperendemic area. Along with these three infected newborns, two
cases of uninfected newborns from infected mothers were reported
[17].
Kalanda et al. described a twin birth from a mother suffering
from first stage HAT [24]. In the first twin, parasites could be
detected in the blood and second-stage congenital HAT was
diagnosed. The second twin was followed up and 6 weeks after
birth, the serological testing became positive and the cell count of
the cerebrospinal fluid indicated second stage HAT. However, the
second twin did not fulfill the criteria of congenital HAT. Both
twins showed normal results at the 6 months post-therapeutic
follow up.
David and Pape reported two newborns—tested immediately
postpartum—with trypanosomes in the peripheral blood and in
the umbilical cord blood. Their mothers appeared healthy and
had been diagnosed through routine testing [20].
Chambon, Pinto, Burke et al., and Kazyumba et al. each
published a single case of congenital HAT diagnosed in the first 5
days of life [19,21–23].
Three cases of children (19, 22, and 24 months old) with second-
stage HAT—born in France and England of infected mothers—
are described. The three children themselves are reported not to
have been in an endemic country, and vertical transmission can be
assumed [26–28]. For example, one of these children was born
with hydrocephalus and second-stage HAT in Marseille, France
(the mother left Chad in the fifth month of her pregnancy [26]).
The proportion of uninfected babies born to infected mothers is
unknown. Besides the two uninfected newborns described by Sina
et al., Darre ´ refers in his publication in 1937 to four cases of
uninfected newborns from infected mothers in a study published
by Thiroux, Lebœuf, and van den Branden [17,26].
In summary, 17 cases of certain vertical transmission could be
identified in the literature: 13 cases with T.b. gambiense and one case
with T.b. rhodesiense diagnosed within 5 days of life, plus three
children of infected mothers, who were diagnosed with HAT and
never entered an endemic country themselves.
Uncertainty of Transmission Route in Older Newborns
Chambon refers in his publication in 1933 to four cases of HAT
in newborns diagnosed at the age of 8 to 12 days observed by Le
Rougic, Montestruc, Montalier, and Jamot [19]. Several other
publications reported children diagnosed beyond 5 days of life in
the newborn period or as very young infants and the authors
assumed vertical transmission [11,18,29–37]. For example, Pepin
et al. stated that one or two cases of congenital transmission among
200 to 400 total cases per year were treated [18]. In this
publication the authors refer to two infants 1 and 3 months old.
However, postnatal infection cannot be excluded in these cases.
The older the child is at the time of diagnosis, the higher the
probability of vector transmission. With increasing age other risk
factors, like shared exposure with the mother, become more
plausible.
Higher Proportion of Second-Stage HAT in Younger
Children
In general, HAT is diagnosed less in younger children than in
adults [4,5]. In the aforementioned study of Triolo et al. in
Cameroon, out of 227 children under 6 years with HAT, 46
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Eperon et al. in Sudan, of 119 infected children under 6 years, 42
(35.3%) were under 1 year old [4]. Assuming an increasing
incidence of vector-transmitted disease with age (longer exposure
to the vector), in those two studies children under 1 year seemed to
be overrepresented.
Among the 119 children under 6 years in Sudan, the proportion
of children in the second stage was higher in very young children
(under 2 years) compared with older children [4]. Even if different
second-stage criteria in regards to the white cell count in the
cerebrospinal fluid complicate the comparison, the predominance
of second-stage HAT in young children is reported in several other
studies as well [5,11,38,39]. Late diagnosis due to an unspecific
initial clinical presentation is a possible explanation [4–7]. A more
rapid progression from first to second stage is discussed by several
authors [4,5,7]. In very young children, more than five white
blood cells/mm
3 may occur in the cerebrospinal fluid without any
pathological process, leading to some over-classification as second
stage [4,40,41].
The higher proportion of second-stage HAT in younger
children points to an infection early in life, and vertical
transmission may be a contributing factor.
Familial Clustering of HAT
Familial aggregation of HAT had already been observed at the
beginning of the 20th century [42]. Me ´da et al. showed familial
clustering in a case control study in Ivory Coast [43]. Khonde et
al. demonstrated, in three adjacent villages in Democratic
Republic of Congo, familial clustering between mothers and
children, and between brothers and sisters [44]. Khonde et al.
discuss behavioural factors, with a shared exposure as the most
plausible explanation for familial clustering of HAT. For example,
breastfeeding mothers usually carry their infants with them and so
both are simultaneously exposed to an infective tsetse fly. They do
state that ‘‘congenital infection may have been involved in some
cases’’. Familial aggregation is also described in two case-control
studies in T.b. rhodesiense [45,46].
The Unknown Prevalence of HAT in Pregnant Women
Women with HAT have increased infertility and abortion rates
[47]. Among 160 women of childbearing age infected with T.b.
gambiense, Sina et al. reported 53 (33%) women with hormonal
disorders, especially amenorrhoea. Furthermore, among them, ten
abortions and seven normal pregnancies were observed [17].
Among 76 women of childbearing age with T.b. rhodesiense HAT,
Buyst et al. described four pregnant women with complications
such as hydramnios, preeclampsia, abortion, stillbirth, and
premature birth in an observation period of 13 months [25].
No published data about the prevalence of HAT in pregnant
women in endemic areas could be found. HAT screening is not
integrated into antenatal care services.
Very few data are available about the prevalence of pregnancy
among treated HAT patients. In two databases in Yei and Kiri,
South Sudan, pregnancies among infected women of childbearing
age were 2.8% (17/606) and 0.7% (8/1191), respectively [48].
However, those retrospective data may considerably underes-
timate the reality. Pregnancy testing is rarely performed on a
routine basis on HAT patients and early pregnancy may be
missed. HAT can be asymptomatic or a little symptomatic in
pregnant women [26,37], and may therefore not be detected in
antenatal care services. Infected pregnant women may await their
delivery at home and present to the health facility for HAT
diagnostics afterwards, resulting in underreporting of abortions,
stillbirths, and early deaths in congenital HAT cases.
Lack of Consistent Databases
HAT databases that were consulted did not routinely record the
pregnancy status of infected women. Furthermore, the link
between infected mother and the status of her newborn or infant
could not be established.
If a newborn is diagnosed, the age is usually recorded in
months. As a result, even a case diagnosed in the first 5 days of life
is likely to be recorded with the age of 1 month. Due to these
limitations, relevant information about congenital HAT cannot be
drawn from existing databases of which we are aware.
Lack of Awareness
As part of a master thesis at the University of Basel, Switzerland,
18 international and local HAT experts were interviewed [48].
Among other things, they were asked if, according to their
experience, newborns of treated breastfeeding HAT patients were
followed up. Five experts stated that newborns were followed up.
Eight experts acknowledged that newborns were followed up if
possible. However, four experts declared that newborns were not
followed up at all.
Vertical transmission of HAT is not mentioned in several
examples of HAT literature, such as a standard textbook of
tropical medicine and a clinical HAT review [3,16].
National HAT guidelines for endemic countries are scarce. The
Me ´decins Sans Frontie `res guideline clearly points out this
transmission route and recommends testing of newborns of
infected mothers [8]. A WHO technical report mentions that
newborns of infected mothers are at risk, but does not specify any
recommendations for screening activities [13]. A reviewed
national guideline for an endemic country did not mention the
vertical transmission route [15]. The occurrence of familial
clustering of cases with consequent recommendations for active
or passive case-finding was not pointed out in the three
aforementioned documents. The guideline of Institut de Recher-
che pour le De ´veloppement does not describe the vertical
transmission route, although it discusses the occurrence of familial
clustering [14].
Recommendations for HAT Guidelines
All HAT guidelines and local HAT protocols should put
emphasis on diagnosing HAT in pregnant women, newborns, and
infants (Box 1).
Box 1. Six Aspects Should Be Stressed in All
HAT Guidelines and Protocols
N Newborns of mothers with HAT should be assessed by
parasitological methods as early as possible (including
umbilical cord blood examination where possible).
N In case of initial negative parasitological results, new-
borns of mothers with HAT should be followed up for at
least 6 months.
N In endemic areas pregnant women should be screened
for HAT.
N Women with HAT of childbearing age should undergo
pregnancy testing.
N Appropriate treatment protocols for infected newborns
and infants should be established.
N Familial clustering of cases should be considered in all
active and passive case-finding strategies.
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months is not known. If suspected of HAT infection, children in
this age group should undergo direct parasite detection exams.
Newborns of infected mothers initially yielding negative results
should be followed up for at least 6 months. This is a reasonable
approach due to the limited sensitivity of direct parasite detection
techniques routinely used in the field [49].
In endemic areas, HAT should be considered in the differential
diagnosis of newborns and infants. The existence of familial
clustering should be borne in mind in all active and passive case-
finding strategies. Especially in the case of an infected mother, the
higher risk of infection of all her children has to be considered.
Screening should be offered to the whole family. This is
particularly relevant in passive case detection, where only an
individual is tested. In active case-finding, relatives of cases who
did not attend the community screening should be systematically
sought [44].
Vertical Transmission Underestimated?
Most case reports of congenital HAT are from the 1970s and
1980s. The resurgence of HAT from the 1960s onwards and its
peak in the mid-1990s did not result in more reported cases,
although more sensible screening and diagnostic methods had
become available. Thirteen cases of congenital infection with T.b.
gambiense diagnosed within 5 days of birth are described in the
literature. It is less surprising than it would appear at first sight that
nearly half of all cases were diagnosed at the hospital of Fontem in
Cameroon [5,17]. Triolo et al. pointed out that at Fontem there
was a co-existence of favourable conditions: a well-functioning
hospital and laboratory, the systematic performance of paediatric
examination during Mother and Child Care clinics, and the
symbiosis between the hospital and the school, which were both
managed by the same mission congregation. Sina et al. drew
attention to the fact that mass campaigns for HAT control leave
little time for research. It should be borne in mind that in several
countries—e.g., Democratic Republic of Congo—HAT screening
and treatments were organized at the village level, far from
hospitals, maternities, and well-functioning laboratories. The
probability of detecting congenital HAT under those circum-
stances was extremely low. Sina et al. were testing the umbilical
cord blood of newborns of mothers either with HAT or suspected
HAT, or those who were resident in endemic areas. Using this
method, they were able to detect three cases of congenital HAT in
a period stated as several months. According to Triolo et al. and
Sina et al., it appears that vertical transmission of HAT occurs
more often than suspected.
In the limited publications on the subject, congenital HAT is
assumed to be rare. Behavioural and spatial risk factors shared
with the mother are a plausible reason for the frequency of
infected infants. However, studies about congenital HAT are
absent and the real risk is unknown.
To Investigate the Unknown Risk
Is congenital HAT rare because infected women rarely give
birth, due to infertility and abortion? Are babies born to infected
mothers mostly exempt from infection? Or is congenital HAT
occurring more often than suspected?
Routine data collection may be a relatively easy step to start
obtaining relevant information. For diagnosed newborns, record-
ing the age in days would better inform the data analyses. The
outcome of pregnancy of infected women could be recorded as
well as the HAT status of their newborns.
To assess the true association of vertical transmission with
abortion, stillbirth, and congenital HAT, further research is
needed. The mechanisms of transplacental passage of trypano-
somes should be investigated as well. Studies on HAT complica-
tions during pregnancy and on congenital HAT are long overdue
and should be promoted despite the often challenging context of
remote areas, political instability, and poorly performing health
services.
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Key Learning Points
N Seventeen cases of certain vertical transmission could be
identified in the literature, plus many more suspected,
for whom vector transmission could not be excluded.
N Generally it is assumed to be a rare event, but it has
never been systematically investigated.
N In two publications it is hypothesized that congenital
HAT occurs more often than suspected.
N Awareness of this transmission route is insufficient and
not enough effort is allocated to detect vertical
transmission of HAT.
N In endemic areas, pregnant women should be screened
for HAT. Newborns of mothers with HAT must be
assessed with parasitological methods as early as
possible and followed up for at least 6 months if initial
results are negative.
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